Odyssey Health enters $25M equity purchase agreement with Mast Hill Fund

Odyssey Health, Inc.

Entered $25M equity purchase agreement with Mast Hill Fund; shares sold at 97% of VWAP discount.
Company may direct Mast Hill to purchase up to $500K or 20% of avg daily trading value per put.
Agreement runs 24 months; company can terminate anytime without penalty.
Proceeds for general corporate purposes, working capital, R&D, and officer compensation.
Mast Hill beneficial ownership capped at 4.99%; no short selling or hedging allowed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.